SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-24-058695
Filing Date
2024-07-02
Accepted
2024-07-02 17:29:48
Documents
1
Group Members
ALUMNI CAPITAL GP LLCASHKAN MAPAR

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea0208855-13galumni_kazia.htm SC 13G 74580
  Complete submission text file 0001213900-24-058695.txt   76385
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Subject) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-50612 | Film No.: 241097208
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 405 LEXINGTON AVE. 9TH FLOOR NEW YORK NY 10174
Business Address 405 LEXINGTON AVE. 9TH FLOOR NEW YORK NY 10174 (818) 438-9794
Alumni Capital LP (Filed by) CIK: 0001912606 (see all company filings)

IRS No.: 873893017 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G